Correlation Between Aurelius Technologies and Duopharma Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aurelius Technologies and Duopharma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aurelius Technologies and Duopharma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aurelius Technologies Bhd and Duopharma Biotech Bhd, you can compare the effects of market volatilities on Aurelius Technologies and Duopharma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aurelius Technologies with a short position of Duopharma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aurelius Technologies and Duopharma Biotech.

Diversification Opportunities for Aurelius Technologies and Duopharma Biotech

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Aurelius and Duopharma is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Aurelius Technologies Bhd and Duopharma Biotech Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Duopharma Biotech Bhd and Aurelius Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aurelius Technologies Bhd are associated (or correlated) with Duopharma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Duopharma Biotech Bhd has no effect on the direction of Aurelius Technologies i.e., Aurelius Technologies and Duopharma Biotech go up and down completely randomly.

Pair Corralation between Aurelius Technologies and Duopharma Biotech

Assuming the 90 days trading horizon Aurelius Technologies Bhd is expected to under-perform the Duopharma Biotech. In addition to that, Aurelius Technologies is 1.34 times more volatile than Duopharma Biotech Bhd. It trades about -0.05 of its total potential returns per unit of risk. Duopharma Biotech Bhd is currently generating about 0.02 per unit of volatility. If you would invest  121.00  in Duopharma Biotech Bhd on September 1, 2024 and sell it today you would earn a total of  2.00  from holding Duopharma Biotech Bhd or generate 1.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aurelius Technologies Bhd  vs.  Duopharma Biotech Bhd

 Performance 
       Timeline  
Aurelius Technologies Bhd 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aurelius Technologies Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Aurelius Technologies is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Aurelius Technologies and Duopharma Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aurelius Technologies and Duopharma Biotech

The main advantage of trading using opposite Aurelius Technologies and Duopharma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aurelius Technologies position performs unexpectedly, Duopharma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Duopharma Biotech will offset losses from the drop in Duopharma Biotech's long position.
The idea behind Aurelius Technologies Bhd and Duopharma Biotech Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk